Title : Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.

Pub. Date : 2018 Feb

PMID : 29110152






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer. Lapatinib phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Homo sapiens